What Do Percs Do? A Clinician’s Guide to How Percocet Affects the Brain and Body, the Signs of Abuse, and the Risks of Long-Term Use

How Percocet works as a combined opioid and paracetamol painkiller, what the high feels like, the short and long term effects on the brain, the body, breathing, and the liver, the signs that recreational use has progressed to abuse and dependence, the risk of opioid use disorder, the danger of overdose, and the treatment pathway for people who have lost control of percs.

Clinically reviewed by Dr. Ponlawat Pitsuwan, Physician and Addiction Medicine Specialist, Phuket Island Rehab.

Percocet, commonly called percs, is a prescription painkiller that contains oxycodone, a semi-synthetic opioid, combined with paracetamol, also known as acetaminophen. The oxycodone binds to mu opioid receptors in the brain, the spinal cord, and the gastrointestinal tract, which produces strong pain relief, slowed breathing, drowsiness, constipation, and at higher doses a sedating and euphoric high. The paracetamol component adds a non-opioid analgesic effect and, at doses above 4 grams per day, can cause severe and potentially fatal liver damage. Taken as prescribed for short periods after surgery or injury percs are effective and usually safe; taken in larger amounts, more often, or for longer than prescribed they produce tolerance within days to weeks, physical dependence within two to four weeks of regular use, and an increasing risk of opioid use disorder. Signs that someone is abusing percs include pinpoint pupils, drowsiness or nodding off, slurred speech, constipation, mood changes, doctor shopping, asking other people for pills, and using more than prescribed. Overdose, which is the leading cause of death in opioid misuse, presents with very slow or stopped breathing, blue lips or fingernails, unresponsiveness, and pinpoint pupils, and requires immediate naloxone and emergency medical care. Treatment for percocet addiction combines medical detox, medication for opioid use disorder including buprenorphine or methadone, residential or outpatient rehabilitation, behavioural therapy, and long-term recovery support.

What percs are and what is actually in the pill

Percs is the common street name for Percocet, a prescription painkiller manufactured in the United States and several other countries as a combined formulation of oxycodone and paracetamol. Oxycodone is a semi-synthetic opioid derived from thebaine, which is one of the natural alkaloids found in the opium poppy. Paracetamol, called acetaminophen in the United States, is a widely used non-opioid analgesic and antipyretic. The combination is intended to provide stronger pain relief than either component alone, with the opioid acting on central pain pathways and the paracetamol acting on peripheral inflammation and on temperature regulation.

A standard percocet tablet contains 2.5, 5, 7.5, or 10 milligrams of oxycodone combined with 325 milligrams of paracetamol. The pills are usually small, round or oval, and stamped with markings that identify the strength and the manufacturer. Several generic versions of the medication are available, and the dose and pill colour vary by brand. Outside the United States the same combination is sold under names including Endocet, Roxicet, and Tylox. Some related products contain hydrocodone or codeine rather than oxycodone, and people who buy pills on the illicit market sometimes do not know what they are actually taking until laboratory testing confirms the contents.

Percs are prescribed in clinical practice for moderate to severe acute pain after surgery, injury, or in selected cancer pain situations. They are not first-line for chronic non-cancer pain because the risks of tolerance, dependence, and opioid use disorder increase with the duration of treatment. The Centers for Disease Control and Prevention guideline for prescribing opioids for chronic pain, originally published in 2016 and revised in 2022, advises that opioids should be reserved for situations in which the expected benefits outweigh the considerable risks, and that the lowest effective dose should be used for the shortest necessary duration.

How percs work in the brain and body

The oxycodone component of percs is a full agonist at mu opioid receptors and to a lesser extent at kappa and delta opioid receptors. Mu receptors are concentrated in the brain regions that process pain including the periaqueductal grey, the thalamus, and the somatosensory cortex; in the spinal cord dorsal horn where pain signals are first relayed; and in the reward circuitry centred on the ventral tegmental area and the nucleus accumbens. When oxycodone binds to a mu receptor it triggers a cascade that reduces the release of pain neurotransmitters, slows the firing of pain-signalling neurons, and increases dopamine release in the reward pathway. The result is dampened pain perception, a sense of relief or wellbeing, and at higher doses a sedating and euphoric high that is the basis for the abuse potential.

The mu opioid receptors in the brainstem control respiration. When oxycodone activates these receptors it slows the rate and depth of breathing, which is the central mechanism of opioid overdose death. Receptors in the gastrointestinal tract slow gut motility, which is why constipation is one of the most consistent effects of opioid use and one that does not improve with tolerance. Receptors in the urinary tract slow urine output. Receptors in pupillary muscles constrict the pupils, producing the small pinpoint pupils that are a hallmark of opioid intoxication.

Paracetamol does not act on opioid receptors. Its mechanism is incompletely understood and probably involves inhibition of cyclooxygenase enzymes in the central nervous system, modulation of endocannabinoid signalling, and activity at TRPA1 channels. It contributes to analgesia and to the reduction of fever but does not produce the high, the slowed breathing, or the dependence associated with the oxycodone. Its toxicity, however, is severe: at doses above approximately 4 grams in 24 hours in adults paracetamol depletes the liver’s glutathione stores, allows the toxic metabolite N-acetyl-p-benzoquinone imine to accumulate, and produces acute liver injury that can progress to fulminant hepatic failure and death without urgent treatment with N-acetylcysteine.

What the percocet high feels like

Taking percocet at a therapeutic dose for legitimate pain typically produces relief from the pain, mild drowsiness, and a quiet sense of relaxation. Many people who have a single short course of percs after surgery experience nothing they would describe as a high; the medication simply makes the pain bearable and allows them to sleep. Side effects at therapeutic dose include nausea, vomiting, constipation, dry mouth, itching, sweating, light-headedness, and sometimes a foggy mental state.

At higher doses, taken by people without severe pain or by those who have developed tolerance, the experience is qualitatively different. Users describe a warm, heavy, soothing feeling that spreads through the body, a sense that worries and pain dissolve, a deep relaxation, and a drowsy euphoria. The drug typically takes 15 to 30 minutes to take effect when swallowed, peaks at 1 to 2 hours, and lasts 4 to 6 hours. Crushing and snorting or injecting the tablet, which is dangerous because of the paracetamol content as well as the abuse risk, produces a faster and more intense onset that users describe as a rush. The high carries a substantial cost: nausea, vomiting, constipation, itching, mental fogginess, and after the dose wears off, an emerging discomfort that often drives the next dose.

Repeated use changes the experience. Tolerance develops to the euphoric effect more quickly than to the constipation, so over time the user needs higher doses to achieve the same high while side effects accumulate. Tolerance to the respiratory depression also develops, but at a slower rate, which is the danger: a regular user can take a dose that would once have produced euphoria and now barely produces a high, and yet still depresses breathing enough to cause overdose if combined with alcohol, benzodiazepines, or other opioids. The pursuit of the original feeling becomes the pursuit of a target that recedes.

Short term effects of percs on the brain and body

The short term effects of percs on the brain include pain relief, drowsiness, mental clouding, slowed reaction time, impaired judgement and decision-making, and at higher doses sedation and euphoria. The effect on the body includes constricted pupils, slowed breathing, lowered heart rate, lowered blood pressure, nausea, vomiting, constipation, dry mouth, itching especially of the face, sweating, and urinary retention. The combination produces a recognisable picture in someone who has just taken a recreational dose: small pupils, droopy eyelids, slow speech, slow thinking, and a tendency to drift into sleep mid-sentence, which is the nodding off that is one of the most distinctive signs of opioid intoxication.

Driving, operating machinery, and other tasks requiring alertness are dangerous while under the influence of percs and remain so for hours after the drug is taken. Combining percs with alcohol, benzodiazepines including xanax and ativan, sleeping pills, other opioids, or sedating antidepressants multiplies the risk of overdose because all of these drugs depress the central nervous system through partly overlapping and partly different mechanisms. The combination of an opioid and a benzodiazepine in particular is responsible for a large fraction of opioid overdose deaths and is the reason that prescribers and patients are now strongly warned against the combination.

The paracetamol in percs adds a non-opioid risk profile. At therapeutic doses paracetamol is well tolerated, but exceeding 4 grams in 24 hours in adults, less in people with chronic alcohol use or pre-existing liver disease, can produce severe and potentially fatal liver damage. A person who takes multiple percs in a day to chase a high can easily exceed the safe paracetamol dose without realising it, particularly if they also use other paracetamol-containing products. Paracetamol overdose is one of the most common causes of acute liver failure in the United States and the United Kingdom and a leading cause of liver transplant from a single cause.

Long term effects of percs

Long term use of percs produces tolerance, physical dependence, and a high risk of opioid use disorder. Tolerance is the requirement for larger doses to achieve the same effect, and it develops over days to weeks of regular use. Physical dependence is the body’s adaptation to the presence of the drug such that stopping or reducing the dose produces a withdrawal syndrome, and it develops within two to four weeks of regular use at therapeutic doses or sooner with higher doses. Opioid use disorder is the cluster of behavioural, cognitive, and physiological features that define addiction in the diagnostic system. Not everyone who develops tolerance and dependence develops opioid use disorder, but most people who take percs regularly for an extended period are at increased risk.

Long term opioid use also produces hormonal changes including reduced testosterone in men and reduced oestrogen and disrupted menstrual cycles in women, with consequent effects on libido, energy, mood, and bone density. Long term use is associated with reduced immune function and increased rates of infection. Chronic constipation can produce haemorrhoids, anal fissures, and rarely bowel obstruction. Sleep architecture is disrupted, with reduced deep sleep and reduced REM sleep, which contributes to fatigue and to mood and cognitive symptoms.

Long term paracetamol use at higher doses contributes to chronic liver damage. The picture is different from acute paracetamol overdose but real: cumulative liver injury over months and years can produce fibrosis and cirrhosis even when individual doses are within or near the recommended limit. The combination of long term oxycodone and long term paracetamol use is harder on the liver than either alone, and the liver damage is often not detected until it is advanced because routine liver function tests can be normal in the early stages.

Signs that perc use has become abuse

The transition from prescribed use to abuse is often gradual and follows recognisable patterns. The most consistent early signs are taking more than the prescribed dose, taking the medication more frequently than prescribed, running out of medication before the scheduled refill, requesting early refills, asking other people for pills, and using the medication for reasons other than pain such as for sleep, anxiety, mood, or recreational effect. A person who has been prescribed percs for legitimate pain may slide into these patterns without recognising them as warning signs.

Behavioural changes include withdrawing from family, friends, and activities that were previously meaningful; declining performance at work, school, or in family roles; mood swings, irritability, and emotional flatness; secretive behaviour around medication; doctor shopping, which is seeing multiple prescribers to obtain overlapping prescriptions; and obtaining pills from non-medical sources including friends, family, the internet, and street dealers. Buying pills on the illicit market introduces the additional risk of counterfeit tablets, which increasingly contain fentanyl rather than oxycodone and are responsible for a large number of unexpected overdose deaths.

Physical signs include constricted pupils, drowsiness or nodding off, slurred speech, slowed movements and reaction times, constipation, weight loss or gain, sweating, itching especially of the face, mood changes from the warm euphoric state shortly after a dose to irritability and discomfort as the dose wears off, and the appearance of withdrawal symptoms in the morning or when a dose is missed. Withdrawal in early opioid dependence presents with anxiety, restlessness, muscle aches, sweating, watery eyes, runny nose, yawning, abdominal cramps, diarrhoea, dilated pupils, and goose flesh, and resolves promptly when the next dose is taken, which reinforces the cycle.

How percocet addiction develops

The development of opioid use disorder follows a recognisable trajectory that can begin with a legitimate prescription or with recreational use from the start. The initial phase is the discovery of the rewarding effect of the drug, whether for pain relief, anxiety relief, sleep, mood, or euphoria. The brain’s reward circuitry tags the drug as a reliable source of positive experience and prioritises behaviour that leads to using it again. With repeated use the circuitry adapts, with reduced sensitivity to other rewards and increased sensitivity to drug cues, which is one of the neurobiological underpinnings of craving.

Tolerance and physical dependence develop in parallel. The user takes more of the drug to achieve the same effect; the body adapts to the higher dose; stopping the drug now produces withdrawal symptoms; the withdrawal is unpleasant enough that the user takes another dose to relieve it. The pattern of using to feel normal rather than to feel high is one of the defining transitions of opioid use disorder. The user may insist that they are not addicted because they no longer feel the high, but the dependence is present and the cycle is established.

Risk factors for developing opioid use disorder from percocet include a family or personal history of substance use disorder, a personal history of mental health conditions including depression, anxiety, post-traumatic stress disorder, attention deficit hyperactivity disorder, and bipolar disorder, a history of childhood trauma or adverse childhood experiences, younger age at first use, higher doses prescribed, longer duration of prescribed use, social environments in which opioid use is normalised, and chronic pain that is not adequately addressed by non-opioid approaches. The presence of these risk factors does not mean a person will develop the disorder, only that the probability is higher.

Percocet, alcohol, and the addiction picture in residential treatment

In residential addiction treatment percocet and other prescription opioids commonly co-occur with alcohol use disorder, with benzodiazepine use, and with other substance use. The combination of opioid and alcohol is particularly dangerous because both drugs depress breathing and the central nervous system, and the combination is overrepresented in fatal overdoses. People who use percs and drink heavily often do not recognise the cumulative risk, may use the drugs at different times, and may experience an unexpected synergistic effect on a particular occasion that produces respiratory depression and overdose.

The clinical assessment of a patient with apparent percocet addiction routinely includes screening for alcohol use disorder using the AUDIT or the AUDIT-C, screening for benzodiazepine use, screening for stimulant use, and screening for mental health conditions including depression, anxiety, post-traumatic stress disorder, and bipolar disorder. Many patients present with the primary problem of one substance and are found on assessment to have a more complex picture that requires integrated treatment of the substance use disorders and the mental health conditions together. Treating one in isolation while the others go unaddressed predicts relapse.

Patients with combined opioid and alcohol use disorder often need a more structured detoxification because the two withdrawal syndromes follow different time courses and carry different risks. Alcohol withdrawal can produce seizures and delirium tremens, which are medical emergencies; opioid withdrawal is profoundly uncomfortable but rarely directly lethal except in special situations including pregnancy. Medical detox in a supervised setting manages both syndromes safely with appropriate medications including benzodiazepines or alternatives for alcohol withdrawal and buprenorphine, methadone, or symptomatic medications for opioid withdrawal.

Percocet overdose: signs and response

Percocet overdose is the most dangerous acute consequence of misuse and is the leading cause of death in opioid use disorder. The classic overdose presentation includes very slow or stopped breathing, blue or grey lips and fingernails from low oxygen, unresponsiveness or coma, pinpoint pupils that are smaller than would be expected, limp body, and pale clammy skin. The person cannot be roused and may make gurgling or snoring sounds called the death rattle as breathing fails. Brain damage from oxygen deprivation begins within minutes; death typically follows within minutes to hours unless breathing is restored.

Naloxone, sold under brand names including Narcan, is an opioid antagonist that reverses the effects of opioids at the receptor and can restore breathing within minutes. Naloxone is available as a nasal spray and as an injection, is available without prescription in many jurisdictions, and is increasingly carried by family members of people who use opioids, by community responders, and by emergency services. The response to suspected opioid overdose is to call emergency services, administer naloxone if available, perform rescue breathing or chest compressions as appropriate, place the person in the recovery position, and stay until help arrives. Naloxone may need to be repeated if the original opioid dose is large or long-acting.

The paracetamol component of percs adds a second danger that naloxone does not address. A person who has taken multiple percs in overdose can have a paracetamol exposure that produces severe liver injury 24 to 72 hours later, when the immediate opioid emergency has been managed. All hospital evaluations of suspected percocet overdose include serum paracetamol levels and consideration of N-acetylcysteine treatment to prevent liver failure. The lifesaving role of naloxone in the acute phase should not obscure the need for full medical evaluation.

Withdrawal from percocet

Withdrawal from percocet follows the general pattern of opioid withdrawal and reflects the brain and body’s adaptation to the drug. Symptoms typically begin 8 to 24 hours after the last dose, peak at 24 to 72 hours, and largely resolve over 5 to 10 days, with some symptoms lingering for weeks. The acute phase includes muscle aches, joint pain, restlessness, anxiety, sleep disruption, sweating, runny nose, watery eyes, yawning, dilated pupils, goose flesh, abdominal cramps, diarrhoea, nausea, and vomiting. Most people describe the experience as severely unpleasant but not directly life-threatening in the absence of complicating conditions.

Beyond the acute phase, the protracted withdrawal syndrome can persist for weeks to months and includes ongoing sleep disturbance, low mood, anhedonia, anxiety, fatigue, irritability, and craving. The protracted phase is a major contributor to relapse because the person no longer has the obvious physical symptoms of acute withdrawal but continues to feel unwell in ways that the drug previously relieved. Medication for opioid use disorder including buprenorphine and methadone substantially reduces the protracted withdrawal experience and is one of the main reasons these medications improve outcomes.

Withdrawal management in a clinical setting typically uses one of three approaches. Buprenorphine, a partial mu opioid agonist, suppresses withdrawal and craving and is initiated once the patient is in moderate withdrawal; it can be continued long term as maintenance treatment. Methadone, a full mu agonist with long half-life, similarly suppresses withdrawal and can be continued as maintenance. Symptomatic management uses clonidine for the autonomic symptoms, loperamide for diarrhoea, antiemetics for nausea, and non-opioid analgesics for pain; it can be used when the patient does not want medication-assisted treatment but produces a more uncomfortable withdrawal and is associated with higher relapse rates.

Treatment for percocet addiction

Effective treatment for percocet addiction combines several components. Medical detoxification is the first phase and manages the withdrawal syndrome safely with appropriate medications. Medication for opioid use disorder, often called MOUD, is the cornerstone of long-term treatment and includes buprenorphine, methadone, and naltrexone. Buprenorphine is widely used in office-based and residential settings and is effective for most patients. Methadone is delivered through specialised clinics and is effective for patients who have not responded to or are not suitable for buprenorphine. Naltrexone, an opioid antagonist available as a long-acting injection, blocks the effect of opioids and is used for patients who have completed detox and want a non-opioid maintenance approach.

Behavioural therapy is the second cornerstone and includes cognitive behavioural therapy, motivational interviewing, contingency management, and trauma-informed therapy for patients with significant trauma histories. Group therapy, family therapy, and twelve-step or alternative peer support are commonly integrated. Treatment for co-occurring mental health conditions including depression, anxiety, and post-traumatic stress disorder is essential because untreated mental health conditions predict relapse.

The setting of treatment depends on the severity of the addiction, the presence of co-occurring conditions, the social environment, and the patient’s preferences. Outpatient treatment with medication and counselling is appropriate for many patients with stable housing and social support. Residential treatment provides 24-hour care, removes the patient from the environment in which use is occurring, and is appropriate for patients with severe addiction, unstable housing, polysubstance use, dual diagnosis with mental health conditions, or repeated relapse from outpatient care. Length of residential treatment is typically 28 to 90 days, with longer programmes producing better outcomes for many patients.

Frequently asked questions about percs

How long do percs stay in the system?

Oxycodone has a half life of about 3 to 5 hours, meaning the drug is mostly cleared from the blood within 24 hours of the last dose. Urine drug tests for oxycodone are typically positive for 1 to 4 days after use; hair tests can detect use for 90 days or more; saliva tests are positive for 1 to 4 days. Paracetamol clears within 24 hours.

Are percs the same as oxycodone?

Percocet contains oxycodone plus paracetamol; OxyContin and immediate-release oxycodone contain oxycodone alone. The oxycodone in percocet is identical to the oxycodone in other products; the difference is the paracetamol, which adds its own pharmacology and its own toxicity profile. Many people use percs and oxycodone interchangeably in street and recreational settings, but the formulations are not identical.

Can you become addicted to percs after a short course?

Most people who take percs for a short course after surgery do not become addicted. The risk increases with longer courses, with higher doses, with a personal or family history of substance use disorder, and with use for reasons beyond pain. Physical dependence can develop in two to four weeks of regular use; this is not the same as addiction but is a step toward it. Stopping at this stage produces mild withdrawal but is manageable with a taper.

Is it dangerous to mix percs with alcohol?

Yes. The combination of percs and alcohol increases the risk of overdose and adds to the liver damage from the paracetamol. Many overdose deaths involve people who took an opioid and drank alcohol without realising the cumulative effect on breathing. The combination should be avoided.

What does perc withdrawal feel like?

Perc withdrawal feels like a severe flu combined with restlessness and anxiety. Muscle aches, joint pain, sweating, watery eyes, runny nose, yawning, abdominal cramps, diarrhoea, and dilated pupils are common. The acute phase lasts 5 to 10 days. A protracted phase of low mood, sleep disruption, and craving can continue for weeks to months. Medication can substantially reduce the severity.

How can someone stop using percs safely?

Sudden cessation is uncomfortable and often produces rapid relapse. Safer approaches include a supervised taper for patients on prescribed therapy, medical detox followed by medication for opioid use disorder for patients with established addiction, and integrated treatment that addresses co-occurring substance and mental health conditions. Self-detox without medical support has a high relapse rate.

Summary

Percocet, or percs, is a prescription painkiller that combines oxycodone, a semi-synthetic opioid, with paracetamol. The oxycodone produces the analgesic effect, the sedation, the slowed breathing, and at higher doses the euphoric high; the paracetamol adds analgesia and antipyretic effect but, at doses above 4 grams in 24 hours, can cause severe liver damage. Short-term effects include drowsiness, mental clouding, constricted pupils, constipation, and at higher doses sedation and euphoria. Long-term effects include tolerance, physical dependence, opioid use disorder, hormonal changes, immune suppression, sleep disruption, and cumulative liver damage. Signs of percocet abuse include taking more than prescribed, doctor shopping, withdrawal between doses, nodding off, and behavioural changes. Overdose presents with very slow or stopped breathing, blue lips, unresponsiveness, and pinpoint pupils, and is reversed with naloxone. Treatment combines medical detox, medication for opioid use disorder, behavioural therapy, and long-term recovery support, often delivered in residential or structured outpatient settings. As Dr. Ponlawat Pitsuwan summarises, “The patients we treat for percocet addiction usually did not set out to develop an opioid use disorder. They were prescribed the medication for legitimate pain, the body adapted, and the line between treatment and dependence was crossed without anyone naming the crossing. Recovery is possible at any point, and the sooner the person enters effective treatment the better the outcome.”

Sources

• Centers for Disease Control and Prevention. CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022. MMWR Recommendations and Reports. 2022;71(3):1-95. https://www.cdc.gov/mmwr/volumes/71/rr/rr7103a1.htm
• National Institute on Drug Abuse. Prescription opioids drug facts. https://nida.nih.gov/publications/drugfacts/prescription-opioids
• Substance Abuse and Mental Health Services Administration. Medications for opioid use disorder. TIP 63. https://store.samhsa.gov/product/TIP-63-Medications-for-Opioid-Use-Disorder-Full-Document/PEP21-02-01-002
• World Health Organization. Opioid overdose. https://www.who.int/news-room/fact-sheets/detail/opioid-overdose
• National Institute for Health and Care Excellence. Opioid dependence: management. https://cks.nice.org.uk/topics/opioid-dependence/
• European Monitoring Centre for Drugs and Drug Addiction. Opioids: health and social responses. https://www.emcdda.europa.eu/publications/mini-guides/opioids-health-and-social-responses_en
• Larochelle MR, Bernson D, Land T, et al. Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study. Annals of Internal Medicine. 2018;169(3):137-145. https://pubmed.ncbi.nlm.nih.gov/29913516/

Percocet, percs, oxycodone, hydrocodone, paracetamol, acetaminophen, opioid, opioids, opioid use disorder, OUD, semi-synthetic opioid, mu opioid receptor, kappa opioid receptor, delta opioid receptor, thebaine, opium poppy, OxyContin, Roxicet, Endocet, Tylox, prescription opioid, painkiller, analgesic, respiratory depression, naloxone, Narcan, opioid overdose, fentanyl, alcohol use disorder, AUD, AUDIT, benzodiazepines, xanax, ativan, addiction, dependence, tolerance, withdrawal, opioid withdrawal, COWS, clinical opiate withdrawal scale, buprenorphine, suboxone, methadone, naltrexone, Vivitrol, medication for opioid use disorder, MOUD, medical detox, residential treatment, outpatient treatment, cognitive behavioural therapy, CBT, motivational interviewing, contingency management, trauma-informed care, twelve-step, AA, NA, SAMHSA, NIDA, CDC, NICE, EMCDDA, WHO, liver damage, hepatotoxicity, N-acetylcysteine, NAC, fulminant hepatic failure, cirrhosis, pinpoint pupils, nodding off, doctor shopping, counterfeit pills, polysubstance use, dual diagnosis, depression, anxiety, PTSD, adverse childhood experiences, ACE, Phuket Island Rehab.